Publications by authors named "D Molino"
Background: The global mpox outbreak which started in May 2022 was caused by a novel clade IIb variant of the mpox virus (MPXV). It differed from the traditional Western and Central Africa disease in transmission patterns and clinical presentation.
Methods: To address the need for detailed clinical and virologic data, we conducted an observational cohort study (MOSAIC) during May 2022-July 2023 in individuals with confirmed MPXV infection enrolled in six European Countries.
Supercapacitors are emerging as energy-efficient and robust devices for electrochemical CO capture. However, the impacts of electrode structure and charging protocols on CO capture performance remain unclear. Therefore, this study develops structure-property-performance correlations for supercapacitor electrodes at different charging conditions.
View Article and Find Full Text PDFArticle Synopsis
- Human mpox, caused by the human mpox virus (hMPXV), typically leads to fever and rash and has seen an unprecedented global outbreak since May 2022, prompting the MOSAIC study to assess clinical outcomes.
- MOSAIC recruits participants of all ages with confirmed mpox, collecting various samples for PCR testing and clinical data over six months to understand the disease better.
- The study quickly commenced within two months of the outbreak, focusing on effective research responses to emerging diseases, with final follow-ups expected in January 2024.
Antibodies effective against the recent Omicron sublineages are missing. By taking advantage of a multi-centric prospective cohort of immunocompromised individuals treated for mild-to-moderate COVID-19, Bruel et al. show that administration of 500 mg of sotrovimab induces serum neutralization and antibody-dependent cellular cytotoxicity of BQ.
View Article and Find Full Text PDFBackground: Monoclonal antibodies (mAbs) targeting the spike of SARS-CoV-2 prevent severe COVID-19. Omicron subvariants BQ.1.
View Article and Find Full Text PDF